screening based on having a 5-year lung cancer risk of at least 1.5% and 2.5% were only 0.7 and 0.8 million, respectively.
The percentage of U.S. lung cancer deaths preventable by screening that would be averted using each eligibility than in 2010). However, those averted by using 5-year lung cancer risk thresholds of 1.5%, 2.0%, and 2.5% decreased by a more modest 2.6, 3.2, and 3.7 percentage points, respectively (approximately 6000 fewer deaths averted in 2015 than in 2010 for each). Using a 5-year lung cancer risk of at least 2.5% instead of USPSTF criteria in 2005 would have prevented 2617 more lung cancer deaths (an increase of 3.5 percentage points) over 5 years (P < 0.001), but in 2015 the difference in prevented deaths increased to 5115 (an increase of 6.4 percentage points) (P < 0.001).
Between 2010 and 2015, the 1.5-million decrease in the number of U.S. ever-smokers eligible for screening by USPSTF criteria was offset by an increase of 1.3 million in the number of U.S. ever-smokers with a 20 -to 29 -packyear history who otherwise met USPSTF criteria (Figure 2) . These smokers may have had sufficiently high individual risk for lung cancer (5) to be eligible for screening by riskbased criteria. The decrease in the number of ever-smokers eligible for screening by USPSTF criteria may continue, because smoking prevalence and intensity have decreased substantially among younger persons in the 2015 U.S. population (a 47% prevalence with a mean of 16.9 cigarettes per day among persons aged 80 years compared with a 34% prevalence with a mean of 11.7 cigarettes per day among persons aged 40 years [P for trend < 0.001]).
Discussion: Although the number of U.S. ever-smokers eligible for lung cancer screening according to USPSTF criteria decreased by 1.5 million between 2010 and 2015, the number eligible for screening based on reaching risk threshold criteria decreased by only one half as much. Because of U.S. population changes related to smoking between 2010 and 2015, adhering to the USPSTF criteria led to fewer ever-smokers being eligible for CT screening and fewer lung cancer deaths being averted by screening. Individual risk-based criteria would screen high-risk smokers currently ineligible for screening using USPSTF criteria, resulting in more modest decreases in the numbers screened and deaths averted. To better capture high-risk smokers and prevent premature deaths from lung cancer, eligibility for lung cancer screening should be based on reaching a cost-effective risk threshold that balances CT screening benefits and harms by using a lung cancer risk tool validated in the U.S. population. The gap in screening effec- Median (interquartile range) 5-y individual risks for lung cancer incidence and death in the absence of computed tomography screening for smoking subgroups in 2015 are as follows: Current smokers with a ≥30 -pack-year history aged 55-80 y: incidence, 3.6% (2.2%-6.4%); death, 2.2% (1.3%-4.1%). Former smokers with a ≥30 -pack-year history aged 55-80 y: incidence, 2.0% (1.2%-3.4%); death, 1.2% (0.7%-2.3%). Current smokers or those who quit ≤15 y ago with a ≥30 -pack-year history aged 50 -55 y: incidence, 1.0% (0.7%-1.4%); death, 0.4% (0.3%-0.7%). Former smokers who quit 15-20 y ago with a ≥30 -pack-year history aged 55-80 y: incidence, 1.4% (1.0%-2.6%); death, 1.0% (0.6%-1.9%). Former smokers who quit ≤15 y ago with a 20 -29 -pack-year history aged 55-80 y: incidence, 1.0% (0.4%-1.5%); death, 0.5% (0.2%-0.9%). Current smokers with a 20 -29 -pack-year history aged 55-80 y: incidence, 1.8% (1.1%-3.0%); death, 1.0% (0.6%-1.7%). Median risks within subgroups in 2005 and 2010 are similar to those in 2015 (all within 0.2%). USPSTF = U.S. Preventive Services Task Force. * See the first footnote for Figure 1 .
